Robert Coutts Named Chief Financial Officer for Achilles Therapeutics

Achilles Therapeutics has promoted Robert Coutts to Chief Financial Officer. He most recently served as Director of Finance for the company. He was previously employed by Syncona and Freeline Therapeutics in a Financial Controller capacity. Prior to that, he served in several finance roles with Wellcome Trust, ultimately serving as Commercial Finance Manager. He began his career with KPMG as an Audit Associate before being promoted to Assistant Manager, Transactions and Restructuring.

Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer based in Stevenage, UK.